Post Date:Feb-08-22
CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models
Author: AcceGen R&D TeamDate Published: 08-Feb-22
- Authors: Haineng Xu, Erin George, Yasuto Kinose, Hyoung Kim, Jennifer B.Shah, Jasmine D.Peake, Benjamin Ferman, Sergey Medvedev, Thomas Murtha, Carter J.Barger, Kyle M.Devins Kurt D’Andrea, Bradley Wubbenhorst, Lauren E.Schwartz, Wei-Ting Hwang, Gordon B.Mills, Katherine L.Nathanson, Adam R.Karpf, Ronny Drapkin, Eric J.Brown, Fiona Simpkins
- Journal: Cell Reports Medicine
- DOI: 10.1016/j.xcrm.2021.100394
- Cited AcceGen Product/Service:
Copyright - Unless otherwise stated all contents of this website are AcceGen™ All Rights Reserved – Full details of the use of materials on this site please refer to AcceGen Editorial Policy – Guest Posts are welcome, by submitting a guest post to AcceGen you are agree to the AcceGen Guest Post Agreement – Any concerns please contact marketing@accegen.com
